Which Hepatitis C Treatment to Start

The hepatitis C treatment landscape has changed dramatically in a few short years, and the pace of change is expected to continue as even more new drugs are approved. Picking the right treatment for each patient depends on medical history, HCV genotype…

By Sony Salzman

Featured

Underwhelming Results From Hepatitis C Vaccine Trial

The 548-person U.S. study found that chronic hepatitis C infection occurred among an identical number of people who received the experimental vaccine compared to people who received a placebo.

By U.S. Department of Health and Human Services

From Incarceration to Post-Release, Local Programs Improve Inmate Care for HIV and Hepatitis C

Two models, one from Washington State and another from Los Angeles County, can be duplicated elsewhere to get people into care, experts say.

By Stephen Hicks

Overdoses and Smoking Are Taking the Lives of People With HIV Who Have Been Cured of Hepatitis C

"Providing HCV treatment alone while neglecting to concurrently address the social determinants of health will do little to improve the health outcomes of the majority of individuals with chronic HCV," the study authors wrote.

By Sean R. Hosein for Canadian AIDS Treatment Information Exchange

New State-Level Maps from HepVu Show Impact of Hepatitis C Epidemic Across the U.S.

The data also reveals an estimated 2.3 million people living with HCV infection in the U.S. between 2013 and 2016, with a high burden in the West and in some Appalachian states.

By Corinna Dan, R.N., M.P.H. for U.S. Department of Health and Human Services

Hepatitis C Treatment Slashes Risk of Cancer and Improves Life Expectancy, Study Finds

Prior studies have indicated that hepatitis C direct-acting antivirals reduce the risk of hepatocellular carcinoma, but this is the first large prospective study to compare outcomes among treated and untreated patients.

By Sony Salzman

New Professional Resources for Providers to Address HIV/HCV Coinfection

Several new HIV/HCV coinfection resources for the HIV workforce were recently released by partners of the U.S. Department of Health and Human Services. Here's the department's quick roundup.

By Corinna Dan, R.N., M.P.H. for U.S. Department of Health and Human Services

Hep C and Drug Abuse Often Go Hand in Hand, but Screening for Infection Lags

The number of people who inject drugs has soared, yet many drug patients are not checked for the virus that can damage the liver.

By Michelle Andrews for Henry J. Kaiser Family Foundation

Not All People Are Equally Vulnerable to Hepatitis C -- New Study

Reseearchers have discovered that very rare interferons, only found in hunter-gatherers from central Africa, are far better able to inhibit HCV infection.

By Connor Bamford and John McLauchlan for The Conversation

CDC Estimates Nearly 2.4 Million Americans Living With Hepatitis C

One percent of the adult population in the U.S. were living with hepatitis C from 2013 through 2016, according to new estimates published by the Centers for Disease Control and Prevention.

By Centers for Disease Control and Prevention

What's Really Behind the Recent Decline in U.S. Hepatitis C Prevalence?

On the surface, a 1.1 million drop in the prevalence of hepatitis C in the U.S. would seem to signal a major victory for the advances made in hepatitis C treatment this decade. But the reality is considerably more complex.

By Sony Salzman